- Home
- BCRX vs SHO Comparison
BCRX vs SHO Comparison
Compare BCRX & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- SHO
- Stock Information
- Founded
- BCRX 1986
- SHO 1995
- Country
- BCRX United States
- SHO United States
- Employees
- BCRX N/A
- SHO N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- SHO Hotels/Resorts
- Sector
- BCRX Health Care
- SHO Consumer Discretionary
- Exchange
- BCRX Nasdaq
- SHO Nasdaq
- Market Cap
- BCRX 1.7B
- SHO 1.7B
- IPO Year
- BCRX 1994
- SHO 1995
- Fundamental
- Price
- BCRX $10.75
- SHO $8.95
- Analyst Decision
- BCRX Buy
- SHO Hold
- Analyst Count
- BCRX 8
- SHO 6
- Target Price
- BCRX $16.75
- SHO $10.00
- AVG Volume (30 Days)
- BCRX 6.8M
- SHO 2.5M
- Earning Date
- BCRX 05-05-2025
- SHO 05-06-2025
- Dividend Yield
- BCRX N/A
- SHO 4.02%
- EPS Growth
- BCRX N/A
- SHO N/A
- EPS
- BCRX N/A
- SHO 0.10
- Revenue
- BCRX $503,485,000.00
- SHO $922,708,000.00
- Revenue This Year
- BCRX $36.61
- SHO $8.77
- Revenue Next Year
- BCRX $13.19
- SHO $3.12
- P/E Ratio
- BCRX N/A
- SHO $91.34
- Revenue Growth
- BCRX 41.67
- SHO N/A
- 52 Week Low
- BCRX $5.92
- SHO $7.45
- 52 Week High
- BCRX $11.11
- SHO $12.41
- Technical
- Relative Strength Index (RSI)
- BCRX 64.20
- SHO 54.92
- Support Level
- BCRX $10.46
- SHO $8.44
- Resistance Level
- BCRX $11.00
- SHO $9.16
- Average True Range (ATR)
- BCRX 0.41
- SHO 0.23
- MACD
- BCRX -0.02
- SHO 0.04
- Stochastic Oscillator
- BCRX 77.78
- SHO 54.26
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.
Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.